Kathleen P. Gallagher, Chief Program Officer at Avidity Biosciences, Inc. ($RNAM), sold shares on the open market six times over the past year, totaling about $581 thousand. Her most recent sale occurred on September 2, 2025. These sales rank 6,132nd among 11,678 individual insiders, below the average sale value of $8.6 million across 6.4 transactions on average. She made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | D | Common Stock | 80303 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.05% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | D | Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.03% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | D | Stock Option (Right to Buy) | 16000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | D | Stock Option (Right to Buy) | 13520 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | D | Stock Option (Right to Buy) | 42480 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.03% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | D | Stock Option (Right to Buy) | 27584 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.02% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | D | Stock Option (Right to Buy) | 13352 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | D | Stock Option (Right to Buy) | 9244 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | D | Stock Option (Right to Buy) | 13829 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | D | Stock Option (Right to Buy) | 22321 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Dec. 17, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | A | Common Stock | 72000 | $0.00 | 122,204.0000 | 150,675,742 | 143.41% | 0.05% |
| Dec. 17, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | F | Common Stock | 8030 | $71.87 | 80,838.0000 | 150,675,742 | 9.04% | 0.01% |
| Dec. 17, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | F | Common Stock | 33336 | $71.87 | 88,868.0000 | 150,675,742 | 27.28% | 0.02% |
| Sept. 2, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 188 | $47.42 | 50,204.0000 | 120,212,301 | 0.37% | 0.00% |
| June 17, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 911 | $30.24 | 50,392.0000 | 120,212,301 | 1.78% | 0.00% |
| June 2, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | M | Common Stock | 5875 | $16.65 | 56,429.0000 | 120,212,301 | 11.62% | 0.00% |
| June 2, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 5875 | $32.48 | 50,554.0000 | 120,212,301 | 10.41% | 0.00% |
| June 2, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | M | Stock Option (Right to Buy) | 5875 | $0.00 | 22,596.0000 | 120,212,301 | 20.64% | 0.00% |
| May 1, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | M | Stock Option (Right to Buy) | 5875 | $0.00 | 28,471.0000 | 120,212,301 | 17.11% | 0.00% |
| May 1, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | M | Common Stock | 5875 | $16.65 | 56,429.0000 | 120,212,301 | 11.62% | 0.00% |
| May 1, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 5875 | $32.40 | 50,554.0000 | 120,212,301 | 10.41% | 0.00% |
| April 1, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | M | Stock Option (Right to Buy) | 329 | $0.00 | 34,346.0000 | 120,212,301 | 0.95% | 0.00% |
| April 1, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | M | Stock Option (Right to Buy) | 5546 | $0.00 | 13,829.0000 | 120,212,301 | 28.62% | 0.00% |
| April 1, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 329 | $27.83 | 50,554.0000 | 120,212,301 | 0.65% | 0.00% |
| April 1, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | M | Common Stock | 329 | $16.65 | 50,883.0000 | 120,212,301 | 0.65% | 0.00% |
| April 1, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 5546 | $27.83 | 50,554.0000 | 120,212,301 | 9.89% | 0.00% |
| April 1, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | M | Common Stock | 5546 | $14.70 | 56,100.0000 | 120,212,301 | 10.97% | 0.00% |
| March 3, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | M | Stock Option (Right to Buy) | 5875 | $0.00 | 19,375.0000 | 120,212,301 | 23.27% | 0.00% |
| March 3, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 5875 | $29.41 | 50,554.0000 | 120,212,301 | 10.41% | 0.00% |
| March 3, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | M | Common Stock | 5875 | $14.70 | 56,429.0000 | 120,212,301 | 11.62% | 0.00% |
| Feb. 3, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 5875 | $32.16 | 50,554.0000 | 0 | 10.41% | 0.00% |
| Feb. 3, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | M | Common Stock | 5875 | $16.65 | 56,429.0000 | 0 | 11.62% | 0.00% |
| Feb. 3, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | M | Stock Option (Right to Buy) | 5875 | $0.00 | 34,675.0000 | 0 | 14.49% | 0.00% |
| Jan. 21, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 1295 | $28.59 | 58,670.0000 | 0 | 2.16% | 0.00% |
| Jan. 21, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 1817 | $28.59 | 56,183.0000 | 0 | 3.13% | 0.00% |
| Jan. 22, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 5629 | $30.16 | 50,554.0000 | 0 | 10.02% | 0.00% |
| Jan. 21, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | S | Common Stock | 670 | $28.60 | 58,000.0000 | 0 | 1.14% | 0.00% |
| Jan. 6, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | A | Common Stock | 25000 | $0.00 | 59,965.0000 | 0 | 71.50% | 0.00% |
| Jan. 6, 2025 | Avidity Biosciences, Inc. | $RNAM | Gallagher Kathleen P. | Chief Program Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |